Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
Status:
Completed
Trial end date:
2019-02-05
Target enrollment:
Participant gender:
Summary
This study is being done to determine if an investigational study drug called Omegaven can
help to improve liver disease thought to be caused by Total Parenteral Nutrition (TPN). TPN
is intravenous feeding (IV feeding tube) that provides patients the nutrients when they are
unable to drink fluid or eat food by mouth.